Brief: Biostage Q2 Loss Per Share $0.37
13/08/2019 12:50
Biostage Inc BSTG.PK :
* BIOSTAGE REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.37
Source text for Eikon: ID:nPn1jKNCYa
Further company coverage: BSTG.PK
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer